+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
From
From
From
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2021 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 70 Pages
  • Global
From
From
TNF Inhibitors - Global Strategic Business Report - Product Thumbnail Image

TNF Inhibitors - Global Strategic Business Report

  • Report
  • March 2024
  • 194 Pages
  • Global
From
From
From
Ankylosing Spondylitis - Pipeline Insight, 2021 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 80 Pages
  • Global
From
From
Loading Indicator